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who was presented to Ain Shams University Hospital complaining of dyspnea on moderate exer-
tion. Echocardiography showed the presence of sterile vegetation on the mitral valve, Libman–
Sacks endocarditis (LSE).
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Libman–Sacks valvular lesions are sterile ﬁbrinous vegetations
that preferentially develop at the left-sided heart valves. Echo-
cardiography is a useful tool for documenting the valvular
involvement and dysfunction as well as disease progression
of the patients with systemic lupus erythematosus (SLE).1 It
is usually asymptomatic; however, cases that needed valve
replacement have been described.2
The present case report describes a patient with SLE, LSE,
and other echocardiographic ﬁndings; like pericardial effusion,
decreased left ventricular function and pulmonary
hypertension.
2. Case report
The patient was a 19-year-old Egyptian lady, student, single,
with the diagnosis of SLE, since 2008 when she presented with3524466.
(M.A. Hamza).
tian Society of Cardiology.
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02skin rashes all over the extremities and butterﬂy rash on her
face, photosensitivity and arthritis in her left knee joint. At
the time of the SLE diagnosis, she presented a normal blood
count, normal urea/creatinine levels, increased ESR, decreased
C3 fraction of complement, C4 at the lower normal range. The
antinuclear antibodies (ANAs) and antinative DNA were
positive.
Echo-Doppler study was done at that time revealing nor-
mal LV dimensions and function with EF = 60%, and a mild
circular pericardial effusion. Treatment was initiated with
prednisone 1 mg/kg/day, with the improvement of her
symptoms.
However, the patient interrupted the treatment for one
year. At 24/04/11, she started to complain of dyspnea on mod-
erate exertion. She was presented to the Ain-Shams University
Hospital to ask for medical advice. Clinical examination
showed her BP = 100/70 and HR 90 bpm. Peripheral pulse
was well felt. Cardiac examination revealed accentuated S2,
and S4 on the apex. Normal chest/abdominal examination.
No skin or oropharyngeal lesions, as well as no arthritis or
any joint deformities were observed.
The electrocardiogram was normal. Transthoracic echocar-
diography was done for the patient showing two vegetations,
ﬁrst one is attached to the ventricular surface of the anterior
mitral valve leaﬂet measuring 16 · 13 mm, and causing mild
mitral regurgitation. While the other one is smaller andg by Elsevier B.V. All rights reserved.
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to the ﬁrst one and measures 0.7 · 0.6 mm.
The LVEF was mildly decreased measuring 48%, the right
sided chambers were dilated with elevated RVSP measuring
60 mm Hg. There was also a mild circular pericardial effusion
with no evidence of tamponade. Other valves showed normal
morphology and ﬂow with no masses or vegetations attached.
Three pairs of blood culture samples were collected from
different sites and all had negative results. Hemoglobin =
11.3 mg/dL, platelets = 252,000 and leukocytes = 6400, creat-
inine = 0.6 mg/dL, normal urinary sediment. Antinative-DNA
antibody was positive and anticardiolipin IgG antibodies (13.6
GPL) were undetermined, whereas IgM was negative, C-reac-
tive protein (CRP) = 3.95 mg/L, C3 was decreased and C4
was normal.
The patient received prednisone (40 mg/day) and enalapril
(10 mg/day) and was discharged after the symptomatic
improvement with a plan of follow up for clinical and echo.
3. Discussion
This is a case report of a patient with SLE (established accord-
ing to the criteria of the American College of Rheumatology),3
who presented with exertional dyspnea, which might have been
caused by the decreased LV function or pulmonary hyperten-
sion. Also, the patient had aseptic vegetation in the mitral
valve with mild MR.
Libman–Sacks endocarditis (otherwise known as verru-
cous, or nonbacterial endocarditis) is the characteristic cardiac
manifestation of the autoimmune disease systemic lupus ery-
thematosus (SLE). Libman and Sacks ﬁrst published a descrip-
tion of these atypical, sterile, verrucous vegetations in 1924.4
Libman–Sacks endocarditis most commonly involves mitral
and aortic valves. However, all 4 cardiac valves and the endo-
cardial surfaces can be involved.5
Valvular abnormalities are often clinically silent, without
signiﬁcant valvular dysfunction. Valvular regurgitation is more
common than stenosis, which is rare. Valvular dysfunction can
result in cardiac failure. Embolic phenomena and secondary
infective endocarditis are uncommon but can result in neuro-
logical and systemic complications.5
In a study with 342 SLE patients, LSE was detected by
Doppler echocardiogram in 11% of the cases, more often in
the mitral valve. After 4 years of follow-up, valve failure
and/or stenosis were frequent, and two patients who were can-
didates for heart surgery died.1 Thus, the diagnosis of LSE is
important and the echocardiogram is currently the best imag-
ing procedure for diagnosis.6
One must also recall that the infectious endocarditis is not
unusual in SLE patients with LSE and a differential diagnosis
is mandatory. In this aspect, three laboratory data are impor-
tant: leukocyte count, CRP levels, and blood cultures.2 The
leukocytes tend to decrease during lupus activity and the oppo-
site occurs in infectious endocarditis. Very high CRP levels
suggest an infectious cause, as lupus patients are less capable
of presenting an exuberant response of this protein; however,for a deﬁnitive differential diagnosis, the blood cultures are
more important.7
In the present case, a diagnosis of LSE was attained, as the
leukocyte count was normal, the CRP was not very elevated
and blood culture samples had negative results.
The combined rate of heart failure, valvular replacement,
thromboembolism, and secondary infective endocarditis has
been reported to be as high as 22% in lupus patients with val-
vular disease, compared with 8% of patients without valvular
disease. Most patients do not have clinically signiﬁcant valvu-
lar dysfunction. Regurgitation is noted on echocardiography
images in 25–61% of lupus patients. The reported patients
who need valve replacement varies from 1% to 8% of cases.8
The occurrence of clinically signiﬁcant embolic phenomena
is thought to be low. Although stroke rates are higher in pa-
tients with lupus and antiphospholipid syndrome, multifacto-
rial etiologies for neurological events are often present,
making the speciﬁc contribution of valvular abnormalities dif-
ﬁcult to determine. The likely prevalence of secondary infective
endocarditis is low, but it has not been widely reported. Poten-
tial contributing factors to infective endocarditis are systemic
lupus erythematosus, medications prescribed for lupus, and
underlying valvular abnormalities.2
There is scarce information in the literature regarding the
treatment of LSE. It is known that the use of corticoids and
immunosuppressive drugs seems to have no effect on valve le-
sions; however, anticoagulation therapy must be used for the
treatment of patients with thromboembolic events.2References
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